Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplantation Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01034163
What this trial is testing

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
Novartis Pharmaceuticals 41
Early research (Phase 1)Study completedNCT00058604
What this trial is testing

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).

Who this might be right for
Epstein-Barr Virus InfectionsLymphoproliferative Disorders
Baylor College of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Not applicableActive Not RecruitingNCT04635384
What this trial is testing

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
CareDx 307
Testing effectiveness (Phase 2)WithdrawnNCT00570999
What this trial is testing

Palifermin After Haploidentical PBSCT

Who this might be right for
Non-Hodgkin's Lymphoma or Hodgkin's DiseaseAcute LeukaemiaMyelodysplastic Syndrome+2 more
European Society for Blood and Marrow Transplantation
Early research (Phase 1)Ended earlyNCT03286114
What this trial is testing

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University of Michigan Rogel Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Not applicableLooking for participantsNCT03810196
What this trial is testing

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes+5 more
Children's Hospital of Philadelphia 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06040320
What this trial is testing

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplant Lymphoproliferative Disorder
Washington University School of Medicine 12
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT01129193
What this trial is testing

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more
Amir Mortazavi 44
Testing effectiveness (Phase 2)Study completedNCT04402138
What this trial is testing

Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Testing effectiveness (Phase 2)UnknownNCT02632396
What this trial is testing

Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission

Who this might be right for
Mantle Cell Lymphoma
Emory University 12
Testing effectiveness (Phase 2)Ended earlyNCT03088709
What this trial is testing

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome+2 more
Loyola University 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT02253316
What this trial is testing

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 236
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Not applicableStudy completedNCT01622582
What this trial is testing

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 796
Next Page